• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

AKT-mTOR信号通路在平滑肌肉瘤的发展中起着关键作用。

The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas.

作者信息

Hernando Eva, Charytonowicz Elizabeth, Dudas Maria E, Menendez Silvia, Matushansky Igor, Mills Joslyn, Socci Nicholas D, Behrendt Nille, Ma Li, Maki Robert G, Pandolfi Pier Paolo, Cordon-Cardo Carlos

机构信息

Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

出版信息

Nat Med. 2007 Jun;13(6):748-53. doi: 10.1038/nm1560. Epub 2007 May 13.

DOI:10.1038/nm1560
PMID:17496901
Abstract

We analyzed the PI3K-AKT signaling cascade in a cohort of sarcomas and found a marked induction of insulin receptor substrate-2 (IRS2) and phosphorylated AKT and a concomitant upregulation of downstream effectors in most leiomyosarcomas. To determine the role of aberrant PI3K-AKT signaling in leiomyosarcoma pathogenesis, we genetically inactivated Pten in the smooth muscle cell lineage by cross-breeding Pten(loxP/loxP) mice with Tagln-cre mice. Mice carrying homozygous deletion of Pten alleles developed widespread smooth muscle cell hyperplasia and abdominal leiomyosarcomas, with a very rapid onset and elevated incidence (approximately 80%) compared to other animal models. Constitutive mTOR activation was restricted to the leiomyosarcomas, revealing the requirement for additional molecular events besides Pten loss. The rapamycin derivative everolimus substantially decelerated tumor growth on Tagln-cre/Pten(loxP/loxP) mice and prolonged their lifespan. Our data show a new and critical role for the AKT-mTOR pathway in smooth muscle transformation and leiomyosarcoma genesis, and support treatment of selected sarcomas by the targeting of this pathway with new compounds or combinations of these with conventional chemotherapy agents.

摘要

我们分析了一组肉瘤中的PI3K-AKT信号级联,发现在大多数平滑肌肉瘤中胰岛素受体底物2(IRS2)和磷酸化AKT显著诱导,且下游效应器同时上调。为了确定异常PI3K-AKT信号在平滑肌肉瘤发病机制中的作用,我们通过将Pten(loxP/loxP)小鼠与Tagln-cre小鼠杂交,在平滑肌细胞谱系中使Pten基因失活。携带Pten等位基因纯合缺失的小鼠出现广泛的平滑肌细胞增生和腹部平滑肌肉瘤,与其他动物模型相比,发病非常迅速且发病率升高(约80%)。组成型mTOR激活仅限于平滑肌肉瘤,这表明除了Pten缺失外还需要其他分子事件。雷帕霉素衍生物依维莫司显著减缓了Tagln-cre/Pten(loxP/loxP)小鼠的肿瘤生长并延长了它们的寿命。我们的数据表明AKT-mTOR途径在平滑肌转化和平滑肌肉瘤发生中具有新的关键作用,并支持通过用新化合物靶向该途径或这些化合物与传统化疗药物联合来治疗某些肉瘤。

相似文献

1
The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas.AKT-mTOR信号通路在平滑肌肉瘤的发展中起着关键作用。
Nat Med. 2007 Jun;13(6):748-53. doi: 10.1038/nm1560. Epub 2007 May 13.
2
Akt-dependent proapoptotic effects of dietary restriction on late-stage management of a phosphatase and tensin homologue/tuberous sclerosis complex 2-deficient mouse astrocytoma.饮食限制对磷酸酶和张力蛋白同源物/结节性硬化症复合物2缺陷型小鼠星形细胞瘤晚期管理的Akt依赖性促凋亡作用。
Clin Cancer Res. 2008 Dec 1;14(23):7751-62. doi: 10.1158/1078-0432.CCR-08-0213.
3
PTEN loss promotes rasHa-mediated papillomatogenesis via dual up-regulation of AKT activity and cell cycle deregulation but malignant conversion proceeds via PTEN-associated pathways.PTEN缺失通过AKT活性的双重上调和细胞周期失调促进rasHa介导的乳头瘤发生,但恶性转化通过PTEN相关途径进行。
Cancer Res. 2006 Feb 1;66(3):1302-12. doi: 10.1158/0008-5472.CAN-05-2341.
4
Targeting the PI3K-AKT-mTOR pathway: progress, pitfalls, and promises.靶向PI3K-AKT-mTOR信号通路:进展、困境与前景。
Curr Opin Pharmacol. 2008 Aug;8(4):393-412. doi: 10.1016/j.coph.2008.08.004. Epub 2008 Aug 27.
5
Mutations in the catalytic subunit of class IA PI3K confer leukemogenic potential to hematopoietic cells.IA类磷脂酰肌醇-3激酶催化亚基的突变赋予造血细胞致白血病潜能。
Oncogene. 2008 Jul 3;27(29):4096-106. doi: 10.1038/onc.2008.40. Epub 2008 Mar 3.
6
Phosphatidylinositol-3-kinase/Akt signaling pathway and kidney cancer, and the therapeutic potential of phosphatidylinositol-3-kinase/Akt inhibitors.磷脂酰肌醇-3-激酶/蛋白激酶B信号通路与肾癌以及磷脂酰肌醇-3-激酶/蛋白激酶B抑制剂的治疗潜力
J Urol. 2009 Dec;182(6):2569-77. doi: 10.1016/j.juro.2009.08.085.
7
Regulation of mammalian target of rapamycin activity in PTEN-inactive prostate cancer cells by I kappa B kinase alpha.IκB激酶α对PTEN失活的前列腺癌细胞中雷帕霉素哺乳动物靶标的活性调节
Cancer Res. 2007 Jul 1;67(13):6263-9. doi: 10.1158/0008-5472.CAN-07-1232.
8
Renal activity of Akt kinase in obese Zucker rats.肥胖 Zucker 大鼠中 Akt 激酶的肾脏活性
Exp Biol Med (Maywood). 2008 Oct;233(10):1231-41. doi: 10.3181/0801-RM-29. Epub 2008 Jul 18.
9
Glucagon-like peptide-1 (GLP-1) protects against methylglyoxal-induced PC12 cell apoptosis through the PI3K/Akt/mTOR/GCLc/redox signaling pathway.胰高血糖素样肽-1(GLP-1)通过PI3K/Akt/mTOR/GCLc/氧化还原信号通路保护细胞免受甲基乙二醛诱导的PC12细胞凋亡。
Neuroscience. 2009 Sep 15;162(4):1212-9. doi: 10.1016/j.neuroscience.2009.05.025. Epub 2009 May 20.
10
IGF-1-stimulated protein synthesis in oligodendrocyte progenitors requires PI3K/mTOR/Akt and MEK/ERK pathways.胰岛素样生长因子-1(IGF-1)刺激少突胶质前体细胞中的蛋白质合成需要磷脂酰肌醇-3激酶(PI3K)/哺乳动物雷帕霉素靶蛋白(mTOR)/蛋白激酶B(Akt)和丝裂原活化蛋白激酶/细胞外信号调节激酶(MEK/ERK)信号通路。
J Neurochem. 2009 Jun;109(5):1440-51. doi: 10.1111/j.1471-4159.2009.06071.x. Epub 2009 Mar 28.

引用本文的文献

1
Translational and clinical comparison of whole genome and transcriptome to panel sequencing in precision oncology.在精准肿瘤学中,全基因组和转录组与基因panel测序在精准度方面的转化与临床比较。
NPJ Precis Oncol. 2025 Jan 10;9(1):9. doi: 10.1038/s41698-024-00788-3.
2
2‑D08 mediates notable anticancer effects through multiple cellular pathways in uterine leiomyosarcoma cells.2-D08 通过多种细胞途径对子宫平滑肌肉瘤细胞发挥显著的抗癌作用。
Oncol Rep. 2024 Jul;52(1). doi: 10.3892/or.2024.8756. Epub 2024 Jun 14.
3
HMGA1 regulates trabectedin sensitivity in advanced soft-tissue sarcoma (STS): A Spanish Group for Research on Sarcomas (GEIS) study.
HMGA1 调节晚期软组织肉瘤(STS)中 trabectedin 的敏感性:西班牙肉瘤研究组(GEIS)的一项研究。
Cell Mol Life Sci. 2024 May 17;81(1):219. doi: 10.1007/s00018-024-05250-y.
4
The Future of Targeted Therapy for Leiomyosarcoma.平滑肌肉瘤靶向治疗的未来
Cancers (Basel). 2024 Feb 26;16(5):938. doi: 10.3390/cancers16050938.
5
PPIP5K2 Facilitates Proliferation and Metastasis of Non-Small Lung Cancer (NSCLC) through AKT Signaling Pathway.PPIP5K2通过AKT信号通路促进非小细胞肺癌(NSCLC)的增殖和转移。
Cancers (Basel). 2024 Jan 30;16(3):590. doi: 10.3390/cancers16030590.
6
Case report: Multiple epstein-barr virus-associated smooth muscle tumours in a child with IL-2-inducible T-cell kinase mutation of undetermined clinical significance.病例报告:一名患有临床意义未明的白细胞介素-2诱导型T细胞激酶突变的儿童发生多例与爱泼斯坦-巴尔病毒相关的平滑肌瘤。
Front Pediatr. 2023 Jul 3;11:1189219. doi: 10.3389/fped.2023.1189219. eCollection 2023.
7
Targeting the biology of aging with mTOR inhibitors.用 mTOR 抑制剂靶向衰老的生物学。
Nat Aging. 2023 Jun;3(6):642-660. doi: 10.1038/s43587-023-00416-y. Epub 2023 May 4.
8
MiR-130b modulates the invasive, migratory, and metastatic behavior of leiomyosarcoma.miR-130b 调节平滑肌肉瘤的侵袭、迁移和转移行为。
PLoS One. 2023 Jan 26;18(1):e0278844. doi: 10.1371/journal.pone.0278844. eCollection 2023.
9
Chloroquine Combined With Rapamycin Arrests Tumor Growth in a Patient-derived Orthotopic Xenograft (PDOX) Mouse Model of Dedifferentiated Liposarcoma.氯喹联合雷帕霉素抑制去分化脂肪肉瘤患者来源的原位异种移植瘤模型的肿瘤生长。
In Vivo. 2022 Nov-Dec;36(6):2630-2637. doi: 10.21873/invivo.12997.
10
ERK5 Is a Major Determinant of Chemical Sarcomagenesis: Implications in Human Pathology.ERK5是化学性肉瘤发生的主要决定因素:对人类病理学的启示。
Cancers (Basel). 2022 Jul 19;14(14):3509. doi: 10.3390/cancers14143509.